目的：分析机器人辅助手术治疗早期宫颈癌的围手术期结果及肿瘤学结局。方法：回顾性分析 2015 年 6 月—2021 年 7 月在浙江大学医学院附属第一医院行机器人辅助手术的 64 例宫颈癌患者的临床资料。结果：64 例 患者均顺利完成手术，无中转开腹病例。根据国际妇产科联盟的临床分期标准，其中ⅠA1 期伴淋巴脉管间隙浸润 （Lymphovascular Space Invasion，LVSI）4 例，ⅠA2 期 4 例，ⅠB1 期 51 例，ⅠB2 期 4 例，ⅡA1 期 1 例。所有患者平均 手术时间为（310.56±71.22）min，平均术中失血量为（144.53±92.75）ml，平均切除淋巴结数量为（23.11±6.97）个， 平均住院时间为（12.27±3.44）d，平均随访时间为（46.48±15.91）个月（3 例失访）。总计 30 例患者接受术后辅 助治疗，其中 13 例接受同步放化疗，15 例接受放疗，2 例接受化疗。随访至今，共 61 例患者存活，其中仅 1 例患 者复发。结论：机器人手术系统在宫颈癌手术中的应用有良好的临床疗效，可以作为治疗早期宫颈癌的有效方法。

Objective: To analyze the perioperative and oncological outcomes of robot-assisted surgery for early cervical cancer. Methods: The clinical data of 64 patients with cervical cancer underwent robot-assisted surgery in the First Affiliated Hospital, Zhejiang University School of Medicine from June 2015 to July 2021 was retrospectively analyzed. Results: All the surgeries were successfully completed without conversion to open surgery. According to the clinical staging criteria of the International Federation of Gynecology and Obstetrics, there were 4 cases of stage I A1 with Lymphovascular Space Involvement (LVSI), 4 cases of stage I A2, 51 cases of stage I B1, 4 cases of stage I B2, and 1 case of stage II A1. The average operative time was (310.56±71.22) min, the average intraoperative blood loss was (144.53±92.75) ml, the average number of dissected lymph nodes was (23.11±6.97), and the average hospital stay was (12.27±3.44) d. 3 cases were lost to follow-up, and the mean followup time was (46.48±15.91) months. A total of 30 cases received postoperative adjuvant therapy, including 13 cases of concurrent chemoradiotherapy, 15 cases of radiotherapy, and 2 cases of chemotherapy. Up to now, 61 cases survived, including 1 case of recurrence. Conclusion: The application of robotic surgical system in cervical cancer has good clinical outcomes, which could be an effective way to treat early cervical cancer.

收稿日期：2022-04-25  录用日期：2022-11-07 

Received Date: 2022-04-25  Accepted Date: 2022-11-07 

基金项目：国家自然科学基金面上项目（82071665） 

Foundation Item: National Natural Science Foundation of China (82071665) 

通讯作者：钱建华，Email：qianjianhua@zju.edu.cn 

Corresponding Author: QIAN Jianhua, Email: qianjianhua@zju.edu.cn 

引用格式：万齐鸿，王雨婷，王哲，等 . 机器人辅助手术治疗早期宫颈癌患者的临床疗效 [J]. 机器人外科学杂志（中英文）， 2023，4（5）：407-412. 

Citation: WAN Q H, WANG Y T, WANG Z, et al. Clinical efficacy of robot-assisted surgery on patients with early cervical cancer[J]. Chinese Journal of Robotic Surgery, 2023, 4(5): 407-412.

[1] Nam J H, Park J Y, Kim D Y, et al. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study[J]. Ann Oncol, 2012, 23(4): 903-911. 

[2] Sert B M, Boggess J F, Ahmad S, et al. Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer[J]. Eur J Surg Oncol, 2016, 42(4): 513-522. 

[3] Lee E J, Kang H, Kim D H. A comparative study of laparoscopic radical hysterectomy with radical abdominal hysterectomy for early-stage cervical cancer: a long-term follow-up study[J]. Eur J Obstet Gynecol Reprod Biol, 2011, 156(1): 83-86. 

[4] Malzoni M, Tinelli R, Cosentino F, et al. Total laparoscopic radical hysterectomy versus abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our experience[J]. Ann Surg Oncol, 2009, 16(5): 1316-1323. 

[5] Ramirez P T, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer[J]. N Engl J Med, 2018, 379(20): 1895-1904. 

[6] Melamed A, Margul D J, Chen L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer[J]. NEnglJ Med, 2018, 379(20): 1905-1914. 

[7] Bhatla N, Berek J S, Cuello Fredes M, et al. Revised FIGO staging for carcinoma of the cervix uteri[J]. Int J Gynaecol Obstet, 2019, 145(1): 129-135. 

[8] Marchal F, Rauch P, Vandromme J, et al. Teleroboticassisted laparoscopic hysterectomy for benign and oncologic pathologies: initial clinical experience with 30 patients[J]. Surg Endosc, 2005, 19(6): 826-831. 

[9] Sert B M, Abeler V M. Robotic-assisted laparoscopic radical hysterectomy (Piver type Ⅲ ) with pelvic node dissection-case report[J]. Eur J Gynaecol Oncol, 2006, 27(5): 531-533. 

[10] Corrado G, Vizza E, Legge F, et al. Comparison of different surgical approaches for stage IB1 cervical cancer patients: a multi-institution study and a review of the literature[J]. Int J Gynecol Cancer, 2018, 28(5): 1020-1028. 

[11] Gallotta V, Conte C, Federico A, et al. Robotic versus laparoscopic radical hysterectomy in early cervical cancer: a case matched control study[J]. Eur J Surg Oncol, 2018, 44(6): 754-759. 

[12] CHEN L, LIU L P, WEN N, et al. Comparative analysis of robotic vs laparoscopic radical hysterectomy for cervical cancer[J]. World J Clin Cases, 2019, 7(20): 3185-3193. 

[13] ZHANG S S, DING T, CUI Z H, et al. Efficacy of robotic radical hysterectomy for cervical cancer compared with that of open and laparoscopic surgery: a separate metaanalysis of high-quality studies[J]. Medicine (Baltimore), 2019, 98(4): e14171. 

[14] Mendivil A A, Rettenmaier M A, Abaid L N, et al. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: a five year experience[J]. Surg Oncol, 2016, 25(1): 66-71. 

[15] Diver E, Hinchcliff E, Gockley A, et al. Minimally invasive radical hysterectomy for cervical cancer is associated with reduced morbidity and similar survival outcomes compared with laparotomy[J]. Minim Invasive Gynecol, 2017, 24(3): 402-406. 

[16] Shah C A, Beck T, Liao J B, et al. Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer[J]. Gynecol Oncol, 2017, 28(6): e82. 

[17] Alfonzo E, Wallin E, Ekdahl L, et al. No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study[J]. Eur J Cancer, 2019. DOI: 10.1016/j.ejca.2019.05.016.